Arrowhead to Present at Upcoming Investor
Rodman & Renshaw Annual Global Investment Conference 2010
April 20, 2010 07:03 AM Eastern Daylight Time
PASADENA, Calif.--(EON: Enhanced Online News)--Arrowhead Research Corporation (Nasdaq:ARWR)
announced today that Dr. Christopher Anzalone, Chief Executive Officer, will be presenting at the following investor
l MDB Bright Lights Conference on May 11, 2010 at 1:30 pm PT in San Francisco, CA. Bright Lights will
feature more than 40 of the "Best and Brightest" IP leaders identified by MDB's PatentVest IP intelligence
platform as possessing technology leadership and potentially disruptive innovation.
l Rodman & Renshaw’s 6th Annual Global Healthcare Conference on May 17, 2010 at 11:55 am BST (6:55
am ET) in London, UK. An audio and slide webcast of the presentation will be available under the
"Presentations and Events" page on the "Investor" section of Arrowhead’s website at
http://www.arrowres.com/conference.html. Following the live presentation, archives will be available for 90
To request a one-on-one meeting with Dr. Anzalone at either conference, please contact Brandi Floberg at
email@example.com or call 212-481-2050.
About Arrowhead Research Corporation
Arrowhead Research Corporation (www.arrowheadresearch.com) (NASDAQ: ARWR) is a nanotechnology
company commercializing new technologies in the areas of life sciences and electronics. Arrowhead is seeking to
build value for shareholders through the progress of its subsidiaries and investments. Currently, Arrowhead is
focused primarily on its two majority owned subsidiaries; Unidym, a leader in carbon nanotube technology for
electronic applications, and Calando, at the forefront of clinical application of RNAi delivery technology. Arrowhead
also has minority investments in two privately held nanobiotech companies.
The Piacente Group
Brandi Floberg, 212-481-2050